title: [Pancreatoxicity during neoadjuvant and adjuvant chemotherapy of HER-negative breast cancer].
authors.forename: A N
authors.initials: AN
authors.lastname: Kaziulin
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Biakhov
authors.forename: I A
authors.initials: IA
authors.lastname: Koroleva
authors.forename: S V
authors.initials: SV
authors.lastname: Kozlov
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Kucheriavyĭ
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000681:Amylases / Q000097:blood; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D016022:Case-Control Studies; D017024:Chemotherapy, Adjuvant; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008049:Lipase / Q000097:blood; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010179:Pancreas / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000201:enzymology; D010195:Pancreatitis / Q000097:blood / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000453:epidemiology; D020893:Receptor, ErbB-3 / Q000096:biosynthesis*; D012189:Retrospective Studies; D014463:Ultrasonography
chemical_list: D004317:Doxorubicin; D020893:Receptor, ErbB-3; D008049:Lipase; D000681:Amylases; D017239:Paclitaxel